XBiotech (XBIT) Non-Current Deferred Tax Liability (2021 - 2026)
XBiotech (XBIT) posted quarterly Non-Current Deferred Tax Liability of $5000.0 for Q4 2025, down 91.53% quarter-over-quarter from $59000.0 in Q4 2022.
XBiotech (XBIT) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends
XBiotech's Non-Current Deferred Tax Liability history runs 3 years deep, the most recent figure standing at $5000.0 for Q4 2025.
- In Q4 2025, Non-Current Deferred Tax Liability changed N/A year-over-year to $5000.0; the TTM figure through Dec 2025 stood at $5000.0 (changed N/A YoY), while the FY2025 annual figure was $5000.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability for Q4 2025 stood at $5000.0, down from $59000.0 in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $873000.0 in Q4 2021, with the low at $5000.0 in Q4 2025.
- The 3-year median for Non-Current Deferred Tax Liability is $490000.0 (2021), against an average of $471375.0.
- Peak annual rise in Non-Current Deferred Tax Liability reached 708.33% in 2022, while the deepest fall reached 93.24% in 2022.
- XBiotech's Non-Current Deferred Tax Liability stood at $873000.0 in 2021, then slumped by 93.24% to $59000.0 in 2022, then tumbled by 91.53% to $5000.0 in 2025.
- Business Quant data shows XBIT's Non-Current Deferred Tax Liability at $5000.0 in Q4 2025, $59000.0 in Q4 2022, and $872000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | XBiotech | 69.51 Mn | 69.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5,000.00 |
| Jun 30, 2026 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2022 | 59,000.00 |
| Dec 31, 2022 | 59,000.00 |
| Sep 30, 2022 | 872,000.00 |
| Sep 30, 2022 | 872,000.00 |
| Jun 30, 2022 | 873,000.00 |
| Jun 30, 2022 | 873,000.00 |
| Mar 31, 2022 | 873,000.00 |
| Mar 31, 2022 | 873,000.00 |
| Dec 31, 2021 | 873,000.00 |
| Dec 31, 2021 | 873,000.00 |
| Sep 30, 2021 | 108,000.00 |
| Sep 30, 2021 | 108,000.00 |
| Jun 30, 2021 | 108,000.00 |
| Jun 30, 2021 | 108,000.00 |